These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8222175)

  • 41. Effects of pimobendan and EGIS 9377, cardiotonic agents, and OG-VI, a nucleoside-nucleotide mixture, administered during reperfusion after ischemia on stunned myocardium in dogs.
    Fukutomi T; Satoh K; Ogoshi S; Ichihara K
    Coron Artery Dis; 2000 Feb; 11(1):83-90. PubMed ID: 10715811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reversible left ventricular dysfunction in coronary disease (part one): myocardial stunning].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(1-2):39-44. PubMed ID: 10953549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in isolated guinea pig heart.
    Sandhu GS; Burrier AC; Janero DR
    Am J Physiol; 1993 Oct; 265(4 Pt 2):H1249-56. PubMed ID: 8238412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced postischemic ATP repletion by pharmacological inhibition of nucleoside washout and catabolism.
    Henrichs KJ; Matsuoka H; Schaper W
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):694-700. PubMed ID: 2457765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of OG-VI, a nucleoside/nucleotide mixture, and its constituents on myocardial stunning in dogs.
    Kano S; Nakai T; Kohri H; Ichihara K
    Coron Artery Dis; 1995 Oct; 6(10):811-8. PubMed ID: 8789674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2.
    Kloner RA; Jennings RB
    Circulation; 2001 Dec; 104(25):3158-67. PubMed ID: 11748117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ATP sparing effect of isoflurane during ischaemia and reperfusion of the canine heart.
    Kanaya N; Kobayashi I; Nakayama M; Fujita S; Namiki A
    Br J Anaesth; 1995 May; 74(5):563-8. PubMed ID: 7772433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myocardial protection with monophosphoryl lipid-A against aortic cross clamping-induced global stunning.
    Abd-Elfattah AS; Guo JH; Goa SP; Elliot GA; Weber P; Mahgoub MA; Marktanner R; Mohamed A
    Ann Thorac Surg; 1999 Nov; 68(5):1954-9. PubMed ID: 10585110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes.
    Kalsi KK; Smolenski RT; Yacoub MH
    Mol Cell Biochem; 1998 Mar; 180(1-2):193-9. PubMed ID: 9546646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective effects of adenosine in the reversibly injured heart.
    Lasley RD; Mentzer RM
    Ann Thorac Surg; 1995 Sep; 60(3):843-6. PubMed ID: 7677544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Myocardial protective effect of rapid cooling shock at reperfusion].
    Ando S; Inoue K; Hanafusa Y; Ozawa A; Sekiguchi S; Yamada M; Takaba T
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Aug; 44(8):1098-107. PubMed ID: 8828366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of methylprednisolone on metabolism and contractility in the stunned myocardium.
    Kawabata H; Takada K; Katori R
    Angiology; 1995 Oct; 46(10):895-904. PubMed ID: 7486210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of nucleoside transport binding sites in the human myocardium.
    Abd-Elfattah AS; Hoehner J; Wechsler AS
    Mol Cell Biochem; 1998 Mar; 180(1-2):105-10. PubMed ID: 9546636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning.
    Randhawa MP; Lasley RD; Mentzer RM
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):63-74. PubMed ID: 7609570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart.
    Peart J; Matherne GP; Cerniway RJ; Headrick JP
    Cardiovasc Res; 2001 Oct; 52(1):120-9. PubMed ID: 11557240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adenosine deaminase inhibitor in cardioplegia enhanced function preservation of the hypothermically stored rat heart.
    Zhu Q; Yang X; Claydon MA; Hicks GL; Wang T
    Transplantation; 1994 Jan; 57(1):35-40. PubMed ID: 8291112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Milrinone and levosimendan administered after reperfusion improve myocardial stunning in swine.
    Shibata I; Cho S; Yoshitomi O; Ureshino H; Maekawa T; Hara T; Sumikawa K
    Scand Cardiovasc J Suppl; 2013 Feb; 47(1):50-7. PubMed ID: 22994851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ATP precursor depletion and postischemic myocardial recovery.
    Bolling SF; Bove EL; Gallagher KP
    J Surg Res; 1991 Jun; 50(6):629-33. PubMed ID: 2051774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Limitation of stunning in dog myocardium by nucleoside and nucleotide mixture, OG-VI.
    Ichihara K; Kano S; Satoh K; Nakai T; Fukutomi T; Okazaki Y; Kohri H
    Nutrition; 1997 May; 13(5):462-4. PubMed ID: 9225340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of allopurinol, erythro-9-(2-hydroxy-3-nonyl)adenine and S-(4-nitrobenzyl)-6-thioinosine on the degradation of adenosine 5'-triphosphate in the rat colon muscularis mucosae.
    Tennant JP; Callaghan F; Turner C; Hourani SM
    J Auton Pharmacol; 1999 Aug; 19(4):229-32. PubMed ID: 10589973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.